DER EINFLUSS DER KOMBINIERTEN APPLIKATION VON PHSOPHOLIPIDEN, PROTHROMBIN-KOMPLEX UND KALZIUMIONEN AUF DIE NORMALE UND DIE DURCH ACETYLSALICYLSAEURE GESTOERTE BLUTGERINNUNG BEI MAEUSEN UND KANINCHEN = L'INFLUENCE DE L'ADMINISTRATION ASSOCIEE DE PHOSPHOLIPIDES, DU COMPLEXE PROTHROMBINIQUE ET D'IONS CALCIUM SUR LA COAGULATION SANGUINE NORMALE ET PERTURBEE PAR L'ACIDE ACETHYLSALICYTIQUE CHEZ LES SOURIS ET LES LAPINSRONNEBERGER H; SCHWINN H.1980; ARZNEIMITTEL-FORSCH.; DEU; DA. 1980; VOL. 30; NO 1; PP. 30-33; ABS. ENG; BIBL. 12 REF.Article

GERINNUNGSAKTIVE PHOSPHOLIPIDE. EIN BEITRAG ZUR GERINNUNGSPHYSIOLOGISCHEN UND CHEMISCHEN CHARAKTERISIERUNG PHOSPHATIDREICHER THROMBOZYTEN- UND PLAZENTAEXTRAKTE = PHOSPHOLIPIDES ACTIFS DANS LA COAGULATION. UNE CONTRIBUTION A LA CARACTERISATION PHYSIOLOGIQUE EN CE QUI CONCERNE LA COAGULATION ET CHIMIE DES EXTRAITS PLAQUETTAIRES ET PLACENTAIRES RICHES EN PHOSPHATIDESTROBISCH H; SCHWINN H.1974; MED. WELT; DTSCH.; DA. 1974; VOL. 25; NO 40; PP. 1604-1608; BIBL. 12REF.Article

FAKTOR VIII-KONZENTRAT, HOCHGEREINIGT UND IN LOESUNG ERHITZT = LE CONCENTRE DE FACTEUR VIII, HAUTEMENT PURIFIE ET CHAUFFE EN SOLUTIONHEIMBURGER N; SCHWINN H; GRATZ P et al.1981; ARZNEIM. FORSCH.; ISSN 0004-4172; DEU; DA. 1981; VOL. 31; NO 4; PP. 619-622; ABS. ENG; BIBL. 18 REF.Article

Improved virus safety and purity of a chromatographically produced factor IX concentrate by nanofiltrationHOFFER, L; SCHWINN, H; BIESERT, L et al.Journal of chromatography. B, Biomedical applications. 1995, Vol 669, Num 2, pp 187-196Article

Application of compact porous disks for fast separations of biopolymers and in-process control in biotechnologySTRANCAR, A; KOSELJ, P; SCHWINN, H et al.Analytical chemistry (Washington, DC). 1996, Vol 68, Num 19, pp 3483-3488, issn 0003-2700Article

Production of highly purified clotting factor IX by a combination of different chromatographic methodsHOFFER, L; SCHWINN, H; JOSIC, D et al.Journal of chromatography. 1999, Vol 844, Num 1-2, pp 119-128, issn 0021-9673Article

Manufacturing and down scaling process for a virus-inactivated pooled human plasmaMORFELD, F; SCHÜTZ, R; JOSIC, D et al.Pharmazeutische Industrie. 1996, Vol 58, Num 5, pp 433-435, issn 0031-711XArticle

Isolation of plasma proteins from the clotting cascade by heparin affinity chromatographyJOSIC, D; BAL, F; SCHWINN, H et al.Journal of chromatography. 1993, Vol 632, Num 1-2, pp 1-10, issn 0021-9673Conference Paper

Manufacture and in vitro characterization of a solvent/detergent-treated human plasmaHELLSTERN, P; SACHSE, H; SCHWINN, H et al.Vox sanguinis (Basel. 1956). 1992, Vol 63, Num 3, pp 178-185, issn 0042-9007Article

Progress in purification of virus-inactivated factor WIII concentrates: three generations of solvent/detergent treated plasma derivatesSCHWINN, H; SMITH, A; WOLTER, D et al.Arzneimittel-Forschung. 1989, Vol 39(2), Num 10, pp 1302-1305, issn 0004-4172Article

Purification of factor VIII and von Willebrand factor from human plasma by anion-exchange chromatographyJOSIC, D; SCHWINN, H; STADLER, M et al.Recombinant products of pharmaceutical interest. Journal of chromatography. B, Biomedical applications. 1994, Vol 662, Num 2, pp 181-190Book Chapter

Extraction of Triton X-100 and its determination in virus-inactivated human plasma by the solvent-detergent methodSTRANCAR, A; RASPOR, P; SCHWINN, H et al.Journal of chromatography. 1994, Vol 658, Num 2, pp 475-481, issn 0021-9673Conference Paper

Size-exclusion chromatography of plasma proteins with high molecular massesJOSIC, D; HORN, H; SCHULZ, P et al.Journal of chromatography. 1998, Vol 796, Num 2, pp 289-298, issn 0021-9673Article

High-performance capillary electrophoresis for in-process control in the production of antithrombin III and human clotting factor IXBUCHACHER, A; SCHULZ, P; CHOROMANSKI, J et al.Journal of chromatography. 1998, Vol 802, Num 2, pp 355-366, issn 0021-9673Article

A solvent I detergent treated, pasteurised and highly purified factor VIII concentrateSCHWINN, H; STADLER, M; JOSIC, D et al.Arzneimittel-Forschung. 1994, Vol 44, Num 2, pp 188-191, issn 0004-4172Article

Affinity chromatography of human blood coagulation factor VIII on monoliths with peptides from a combinatorial libraryAMATSCHEK, K; NECINA, R; HAHN, R et al.HRC. Journal of high resolution chromatography. 2000, Vol 23, Num 1, pp 47-58, issn 0935-6304Article

Removal of parvovirus B19 from contamined factor VIII during fractionationSCHWARZ, T. F; ROGGENDORF, M; HOTTENTRAGER, B et al.Journal of medical virology. 1991, Vol 35, Num 1, pp 28-31, issn 0146-6615Article

Application of compact porous tubes for preparative isolation of clotting factor VIII from human plasmaSTRANCAR, A; BARUT, M; PODGORNIK, A et al.Journal of chromatography. 1997, Vol 760, Num 1, pp 117-123, issn 0021-9673Conference Paper

Issues in the development of medical products based on human plasmasJOSIC, D; SCHULZ, P; BIESERT, L et al.Journal of chromatography. B, Biomedical sciences and applications. 1997, Vol 694, Num 2, pp 253-269, issn 1387-2273Article

Development and biochemical characterization of a double-virus-inactivated factor VIII preparationROBINSON, S; SCHWINN, H; JOSIC, D et al.Blood coagulation & fibrinolysis. 1995, Vol 6, pp S40-S47, issn 0957-5235, SUP2Conference Paper

Molecular defects in coagulation Factor VIII and their impact on Factor VIII functionSAENKO, E. L; ANANVEVA, N; KOUIAVSKAIA, D et al.Vox sanguinis (Basel. 1956). 2002, Vol 83, Num 2, pp 89-96, issn 0042-9007Article

Use of surface plasmon resonance for studies of protein-protein and protein-phospholipid membrane interactions: Application to the binding of factor VIII to von Willebrand factor and to phosphatidylserine-containing membranesSAENKO, E; SARAFANOV, A; GRECO, N et al.Journal of chromatography. 1999, Vol 852, Num 1, pp 59-71, issn 0021-9673Conference Paper

Peptide affinity chromatography of human clotting factor VIII screening of the vWF-binding domainNECINA, R; AMATSCHEK, K; SCHALLAUN, E et al.Journal of chromatography. B, Biomedical sciences and applications. 1998, Vol 715, Num 1, pp 191-201, issn 1387-2273Article

Use of compact, porous units with immobilized ligands with high molecular masses in affinity chromatography and enzymatic conversion of substrates with high and low molecular massesJOSIC, D; SCHWINN, H; STRANCAR, A et al.Journal of chromatography. 1998, Vol 803, Num 1-2, pp 61-71, issn 0021-9673Article

Degradation products of factor VIII which can lead to increased immunogenicityJOSIC, D; BUCHACHER, A; KANNICHT, C et al.Vox sanguinis (Basel. 1956). 1999, Vol 77, pp 90-99, issn 0042-9007, SUP1Conference Paper